WORLD CANCER AWARENESS DAY

🌍WORLD CANCER AWARENESS DAY🌍

🎗️ "Close the Care Gap" 🎗️

🧬 Cancer affects millions worldwide, yet many face barriers to quality care.

let's unite to close these gaps and make cancer care equitable and accessible for all, regardless of location, income, or background.

Together, we can push for early detection, timely treatment, and comprehensive support systems to improve survival rates and quality of life.

Join us in spreading awareness and advocating for change. Every action counts in the journey toward a world without cancer.

#WorldCancerAwarenessDay #CloseTheCareGap #CancerAwareness #HealthForAll #EndCancer #TogetherAgainstCancer

Popular posts from this blog

FINDING LAUGHTER IN UNEXPECTED MOMENTS: A LESSON IN BEING PREPARED

Image
Today's blog is about an experience I had while visiting a religious site on the outskirts of town. As I was leaving, a lady approached me, asking for a donation. Unfortunately, I wasn’t carrying any cash at the time, so I asked her, "Do you use UPI by any chance?" She burst into laughter 😄, smiling at my unexpected question. The lesson here is that we should always be prepared with alternatives, as they might be a way to help others.  At the very least, I managed to put a smile on her face, which made the encounter worthwhile 😊
Read more

CHROMOSOMAL MICROARRAY VS. WHOLE EXOME SEQUENCING

Image
“𝓜𝓲𝓬𝓻𝓸𝓪𝓻𝓻𝓪𝔂𝓼 𝓱𝓮𝓵𝓹 𝓾𝓼 𝓯𝓲𝓷𝓭 𝓶𝓲𝓼𝓼𝓲𝓷𝓰 𝓸𝓻 𝓮𝔁𝓽𝓻𝓪 𝓬𝓱𝓻𝓸𝓶𝓸𝓼𝓸𝓶𝓪𝓵 𝓹𝓲𝓮𝓬𝓮𝓼; 𝓦𝓔𝓢 𝓽𝓪𝓴𝓮𝓼 𝓾𝓼 𝓭𝓮𝓮𝓹𝓮𝓻, 𝓲𝓷𝓽𝓸 𝓽𝓱𝓮 𝓬𝓸𝓭𝓲𝓷𝓰 𝓻𝓮𝓰𝓲𝓸𝓷𝓼 𝔀𝓱𝓮𝓻𝓮 𝓻𝓪𝓻𝓮 𝓿𝓪𝓻𝓲𝓪𝓷𝓽𝓼 𝓱𝓲𝓭𝓮.” — Ellen Matloff 🧬 Chromosomal Microarray (CMA) and Whole Exome Sequencing (WES) are cornerstones of modern genomic diagnostics. Each offers unique insights: CMA identifies large-scale structural changes like copy number variations (CNVs), while WES investigates the exome; the protein-coding portion where most pathogenic mutations reside. 🔹 CMA is a first-line tool for neurodevelopmental disorders, intellectual disability, and congenital anomalies. It scans for chromosomal imbalances missed by karyotyping, offering ~15–20% diagnostic yield in such cases. Its speed and cost-effectiveness make it a go-to for initial evaluations. 🔹 WES, by contrast, dives into the exonic 1–2% of the genome that harbors ~85% of known disease-causing ...
Read more